Remdesivir, Molnupiravir and Nirmatrelvir remain active against SARS-CoV-2 Omicron and other variants of concern

We assessed the in vitro antiviral activity of remdesivir and its parent nucleoside GS-441524, molnupiravir and its parent nucleoside EIDD-1931 and the viral protease inhibitor nirmatrelvir against the ancestral SARS-CoV2 strain and the five variants of concern including Omicron. VeroE6-GFP cells we...

Descripción completa

Detalles Bibliográficos
Autores principales: Vangeel, Laura, Chiu, Winston, De Jonghe, Steven, Maes, Piet, Slechten, Bram, Raymenants, Joren, André, Emmanuel, Leyssen, Pieter, Neyts, Johan, Jochmans, Dirk
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8785409/
https://www.ncbi.nlm.nih.gov/pubmed/35085683
http://dx.doi.org/10.1016/j.antiviral.2022.105252

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8785409/
https://www.ncbi.nlm.nih.gov/pubmed/35085683
http://dx.doi.org/10.1016/j.antiviral.2022.105252

Ejemplares similares